KRM Ayurveda IPO Subscription Status
The KRM Ayurveda IPO has been subscribed 0x times overall. Retail investors are yet to fully participate. Data last updated on 09 Apr, 05:50 PM.
The IPO subscription period has ended. The issue is currently undersubscribed, presenting a higher chance of allotment for applicants. The issue opened on 19 Jan, 2026 and closes on 21 Jan, 2026. The shares are expected to list on stock exchanges on 27 Jan, 2026.
Table of Contents
Live Bidding
| Category | Offered | Applied | Bid Details | TIMES |
|---|---|---|---|---|
|
QIB
|
10,32,000 | 0 |
0
of 10,32,000
|
-- |
|
NII
|
7,80,000 | 0 |
0
of 7,80,000
|
-- |
|
Retail
|
18,12,000 | 0 |
0
of 18,12,000
|
-- |
| TOTAL | 36,24,000 | 0 |
0
-
|
0x |
Last Updated: 09 Apr 2026, 05:50 PM
Day-wise Subscription History
Subscription trends over the last 6 days
| Date | Total | ||
|---|---|---|---|
|
26 Feb 2026
DAY 6
|
-
|
||
|
QIB
-x
NII
-x
Retail
-x
|
|||
|
06 Feb 2026
DAY 5
|
0.00x
|
||
|
QIB
0.00x
NII
0.00x
Retail
0.00x
|
|||
|
22 Jan 2026
DAY 4
|
-
|
||
|
QIB
-x
NII
-x
Retail
-x
|
|||
|
21 Jan 2026
DAY 3
|
1.79x
|
||
|
QIB
0.00x
NII
2.50x
Retail
2.49x
|
|||
|
20 Jan 2026
DAY 2
|
2.80x
|
||
|
QIB
0.00x
NII
4.44x
Retail
3.68x
|
|||
|
19 Jan 2026
DAY 1
|
0.47x
|
||
|
QIB
0.00x
NII
1.18x
Retail
0.16x
|
|||
IPO Guru on Android
Get live GMP alerts, subscription updates, and allotment status directly on your phone. Fast, Free, and Secure.
KRM Ayurveda IPO Allotment Probability
Allotment probability is calculated based on current subscription multiples. Retail allotment is by lottery when oversubscribed; NII allotment is proportionate. Final numbers may change until subscription closes. This is not investment advice.
What Does This Subscription Data Mean?
IPO subscription data tells you how much demand exists for the shares being offered, broken down by investor category. Understanding each category helps you gauge the real sentiment behind the numbers:
- QIB (Qualified Institutional Buyers) — includes mutual funds, FIIs, insurance companies, and banks. QIBs do deep due diligence before bidding. A QIB subscription above 10x is a strong institutional endorsement. Watch QIB numbers closely on the final day — they often hold back and flood in after 3 PM.
- NII / HNI (Non-Institutional Investors) — high-net-worth individuals bidding above ₹2 lakh. NII allotment is proportionate (not lottery), so higher NII subscription means smaller per-lot allotment. Big HNI (B-HNI) bids above ₹10 lakh; Small HNI (S-HNI) bids ₹2–10 lakh.
- Retail — individual investors bidding up to ₹2 lakh. When retail is below 1x, everyone who applied gets full allotment. When oversubscribed, SEBI mandates a computerised lottery — only 1 lot per successful applicant regardless of how many lots you apply for.
- Overall Subscription — a blended multiple across all categories. A total subscription above 10x is considered strong; above 50x is exceptional and usually predicts strong listing gains.
Data sourced from BSE/NSE. Subscription numbers are updated during market hours (10 AM – 5 PM IST) on active subscription days.
Frequently Asked Questions
What is the current subscription status of KRM Ayurveda IPO?
As of IPO close date (21 Jan, 2026), the KRM Ayurveda IPO is subscribed 0x times. Retail category is 0x, and NII is 0x subscribed.
When is the allotment date for KRM Ayurveda IPO?
The allotment for KRM Ayurveda IPO is expected to be finalized on 22 January, 2026.
What is the GMP of KRM Ayurveda?
The Grey Market Premium (GMP) for KRM Ayurveda is currently ₹19, indicating a potential listing gain of 14%.
When will KRM Ayurveda IPO list on the stock market?
KRM Ayurveda is scheduled to list on BSE and NSE on 27 January, 2026.
How to check KRM Ayurveda IPO allotment status?
After the allotment date (22 Jan, 2026), you can check your KRM Ayurveda IPO allotment status on IPO Guru's allotment checker, on the BSE/NSE website using your PAN or application number, or through your broker's app.
Explore KRM Ayurveda IPO Further
Track every stage of this IPO from subscription to listing:
Discussion 0
No comments yet
Be the first to share your thoughts!